FreeTheAI

Geron Corporation Grants 570,000 Stock Options to Three New Hires

NeutralLow impact
GERN$1.20 2.56%

Geron Corporation (GERN) has granted stock options to buy 570,000 shares of common stock to three newly hired employees as a compensation inducement. The awards, effective October 16, 2026, carry an exercise price of $1.17 per share, matching the closing price of the company's common stock on the grant date.

Inducement grants allow public companies to recruit talent outside of standard shareholder-approved equity plans while staying compliant with Nasdaq listing guidelines. The options feature a 10-year term and vest over four years, beginning with 12.5% vesting after six months of employment and the remaining shares vesting in equal monthly installments over the following 42 months.

Investors will continue watching commercial and clinical developments for Geron, including sales of its approved blood cancer treatment RYTELO and progress in its pivotal Phase 3 trial studying imetelstat for myelofibrosis. Shares of Geron traded up 2.14% to $1.195 following the news.

Key points

  • Geron Corporation granted stock options for 570,000 common shares to three new hires as an employment inducement.
  • The options carry an exercise price of $1.17 per share, equal to the closing market price on October 16, 2026.
  • The equity awards feature a 10-year term and vest over four years, starting with 12.5% vesting at the six-month mark.
  • The grants were authorized by the board compensation committee under Nasdaq Listing Rule 5635(c)(4).

Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org

How we writeDisclaimer

Questions and answers

How many stock options did Geron Corporation grant?

Geron Corporation granted stock options to purchase an aggregate of 570,000 shares of common stock to three newly hired employees.

What is the exercise price and vesting schedule for Geron's stock options?

The exercise price is $1.17 per share. The options have a 10-year term and vest over four years, with 12.5% vesting after six months and the rest vesting monthly over the next 42 months.